Target intelligence / Profile preview

ATP-binding cassette sub-family C member 4 (ABCC4)

Target
ABCC4
Molecular classification
Transporter, ATP-binding cassette transporter
01

Overview

ATP-binding cassette sub-family C member 4 (ABCC4), also known as multidrug resistance-associated protein 4 (MRP4), is an ATP-dependent efflux transporter that plays a critical role in cellular detoxification and signaling. It actively extrudes a wide variety of endogenous molecules, including cyclic nucleotides (cAMP and cGMP), eicosanoids (prostaglandins and leukotrienes), bile acids, and steroid conjugates, thereby regulating intracellular signaling pathways and cellular communication. In addition to its physiological roles, ABCC4 is highly implicated in clinical drug resistance, as it effluxes numerous therapeutic agents such as anticancer drugs (e.g., thiopurines, methotrexate, and camptothecins), antivirals, and antibiotics. Overexpression of ABCC4 is observed in several aggressive cancers, including neuroblastoma, pancreatic cancer, and breast cancer, where it contributes to chemotherapy failure and tumor progression. Consequently, ABCC4 is a key therapeutic target for overcoming multidrug resistance, and its genetic polymorphisms serve as important pharmacogenetic biomarkers for predicting drug toxicity and optimizing patient treatment.

Other names
Multidrug resistance-associated protein 4MRP4Multi-specific organic anion transporter BMOAT-BMOATBATP-binding cassette subfamily C member 4
02

Mechanism of action

Inhibition of ATP-dependent efflux activity to prevent the extrusion of therapeutic substrates and increase their intracellular accumulation

03

Biological functions

Active transportEfflux of organic anionsSignal transductionCellular communicationEicosanoid transportNucleotide transport
04

Disease associations

CancerMultidrug resistanceInflammationGoutDrug-induced liver injury
05

Safety considerations

Increased systemic toxicity of substrate drugs (e.g., bone marrow suppression from thiopurines)Altered drug disposition and clearanceImpaired dendritic cell migration and immune responseIncreased risk of drug-induced liver injury or cholestasis
06

Interacting drugs

12 more in the full profile.

07

Biomarkers

ABCC4 expression levelABCC4 genetic variants (e.g., rs3765534 / G2269A, rs2274407, rs4588940, rs1729767, rs7035753)

Beyond the preview

Go deeper on ATP-binding cassette sub-family C member 4 (ABCC4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette sub-family C member 4 (ABCC4).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call